148 related articles for article (PubMed ID: 7003380)
1. Pyrazolopyrimidine metabolism in African trypanosomes: metabolic similarities to Trypanosoma cruzi and Leishmania spp.
Berens RL; Marr JJ; Brun R
Mol Biochem Parasitol; 1980 Apr; 1(2):69-73. PubMed ID: 7003380
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolopyrimidine metabolism in the pathogenic trypanosomatidae.
Marr JJ; Berens RL
Mol Biochem Parasitol; 1983 Apr; 7(4):339-56. PubMed ID: 6192336
[TBL] [Abstract][Full Text] [Related]
3. Differential metabolism of allopurinol and derivatives in Trypanosoma rangeli and T. cruzi culture forms.
Avila JL; Avila A; de Casanova MA
Mol Biochem Parasitol; 1981 Dec; 4(5-6):265-72. PubMed ID: 6174862
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of pyrazolo(3,4-d)pyrimidines in Leishmania braziliensis and Leishmania donovani. Allopurinol, oxipurinol, and 4-aminopyrazolo(3,4-d)pyrimidine.
Nelson DJ; Bugge CJ; Elion GB; Berens RL; Marr JJ
J Biol Chem; 1979 May; 254(10):3959-64. PubMed ID: 438170
[TBL] [Abstract][Full Text] [Related]
5. Pyrazolopyrimidine metabolism in Leishmania: an overview.
Marr JJ
Adv Exp Med Biol; 1984; 165 Pt A():231-7. PubMed ID: 6720385
[TBL] [Abstract][Full Text] [Related]
6. Pyrazolopyrimidine metabolism in Leishmania and trypanosomes: significant differences between host and parasite.
Marr JJ
J Cell Biochem; 1983; 22(3):187-96. PubMed ID: 6365937
[TBL] [Abstract][Full Text] [Related]
7. Differences in allopurinol and 4-aminopyrazolo(3,4-d) pyrimidine metabolism in drug-sensitive and insensitive strains of Trypanosoma cruzi.
Avila JL; Avila A; Monzón H
Mol Biochem Parasitol; 1984 Apr; 11():51-60. PubMed ID: 6379452
[TBL] [Abstract][Full Text] [Related]
8. Inosine analogs as chemotherapeutic agents for African trypanosomes: metabolism in trypanosomes and efficacy in tissue culture.
Fish WR; Marr JJ; Berens RL; Looker DL; Nelson DJ; LaFon SW; Balber AE
Antimicrob Agents Chemother; 1985 Jan; 27(1):33-6. PubMed ID: 3985595
[TBL] [Abstract][Full Text] [Related]
9. Effect of allopurinol on Trypanosoma cruzi: metabolism and biological activity in intracellular and bloodstream forms.
Berens RL; Marr JJ; Steele da Cruz FS; Nelson DJ
Antimicrob Agents Chemother; 1982 Oct; 22(4):657-61. PubMed ID: 6817705
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma brucei: expression of multiple purine transporters prevents the development of allopurinol resistance.
Natto MJ; Wallace LJ; Candlish D; Al-Salabi MI; Coutts SE; de Koning HP
Exp Parasitol; 2005 Feb; 109(2):80-6. PubMed ID: 15687014
[TBL] [Abstract][Full Text] [Related]
11. Antitrypanosomal effect of allopurinol: conversion in vivo to aminopyrazolopyrimidine nucleotides by Trypanosoma curzi.
Marr JJ; Berens RL; Nelson DJ
Science; 1978 Sep; 201(4360):1018-20. PubMed ID: 356267
[TBL] [Abstract][Full Text] [Related]
12. Methylglyoxal metabolism in trypanosomes and leishmania.
Wyllie S; Fairlamb AH
Semin Cell Dev Biol; 2011 May; 22(3):271-7. PubMed ID: 21310261
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of action of pyrazolopyrimidines in Leishmania donovani.
Looker DL; Marr JJ; Berens RL
J Biol Chem; 1986 Jul; 261(20):9412-5. PubMed ID: 2424909
[TBL] [Abstract][Full Text] [Related]
15. Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania.
Bodley AL; Shapiro TA
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3726-30. PubMed ID: 7731973
[TBL] [Abstract][Full Text] [Related]
16. Use of Zymography in Trypanosomiasis Studies.
Monte JFS; Moreno CJG; Monteiro JPMFL; de Oliveira Rocha HA; Ribeiro AR; Silva MS
Methods Mol Biol; 2017; 1626():213-220. PubMed ID: 28608214
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID: 7073876
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]